Band 3, the major protein of the human erythrocyte membrane, associates with multiple metabolic, ion transport, and structural proteins. Functional studies demonstrate that the oxygenation state of the erythrocyte regulates cellular properties performed by these and/or related proteins. Because deoxyhemoglobin, but not oxyhemoglobin, binds band 3 reversibly with high affinity, these observations raise the hypothesis that hemoglobin might regulate erythrocyte properties through its reversible, oxygenation-dependent association with band 3. To explore this hypothesis, we have characterized the binding site of deoxyHb on human erythrocyte band 3. We report that: i) deoxyHb binds to residues 12-23 of band 3; ii) mutation of residues on either side of this sequence greatly enhances affinity of deoxyHb for band 3, suggesting that evolution of a higher affinity interaction would have been possible had it been beneficial for survival; iii) Hb does not bind to two other sequences in band 3 despite their high sequence homology to residues 12-23, and iv) the Hb binding site on band 3 lies proximal to binding sites for glycolytic enzymes, band 4.1 and ankyrin, suggesting possible mechanisms through which multifarious erythrocyte properties might be regulated by the oxygenation state of the cell.
Introduction
Several lines of evidence suggest that the oxygenation state of the erythrocyte (RBC) regulates multiple erythrocyte properties. First, the activities of many membrane solute transporters change with the oxygen content of the cell, including volume regulatory transporters (e.g. Na + /H + exchanger), cation coupled Cl -cotransporters, amino acid transporters, and ion channels. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The K/Cl cotransporter, for example, is reported to be 20-fold more active in oxygenated than deoxygenated RBCs. 9, 10 Second, erythrocyte metabolism is modulated by the O 2 tension of the medium. Thus, glucose flux through the pentose phosphate pathway proceeds twice as rapidly in oxygenated as deoxygenated cells, and glucose consumption in glycolysis is inhibited by oxygenation. In searching for a mechanism to account for oxygenation effects on red cell properties, identification of both the O 2 sensor and downstream effector was considered important. A major candidate for the O 2 sensor was presumed to be Hb, since the O 2 dependence of the above properties generally follows the O 2 dissociation curve of Hb. 4, 12, 13 The downstream effector has been more uncertain, but band 3 has represented the prime candidate, since it constitutes the only established binding site of Hb on the membrane. Moreover, multiple observations document that the interaction between Hb and band 3 is O 2 dependent, where association has been found to occur primarily, if not exclusively, with deoxygenated Hb. 14, 15 Thus, the cytoplasmic domain of band 3 (cdb3) is known to shift the O 2 dissociation curve of Hb to higher O 2 pressures, 15 suggesting preferential association with deoxyHb. Further, an N-terminal peptide of band 3 has been shown by X-ray crystallography to bind within the central cavity of the deoxyHb tetramer. 15 Because this cavity is occluded in oxyHb, the 
Materials and Methods
Construction, expression, and purification of recombinant band 3 mutants.
Wild-type and mutant isoforms of both N-and C-terminal domains of band 3 were prepared as previously described.
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A schematic representation of human cdb3 and the mutants used in this study is shown in Fig. 1 .
Hb preparation.
Human blood was drawn from healthy, non-smoking adults after informed consent. Plasma was removed by washing the cells 3x in PBS and the buffy coat was carefully aspirated following each centrifugation to assure depletion of white cells. Washed erythrocytes were
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The hemoglobin-rich supernatant was bubbled with O 2 for 5 min to partially dissociate 2,3-bisphosphoglycerate (2,3-BPG), and the Hb was purified by gel filtration and ion-exchange chromatography to deplete 2,3-BPG and remove any possible denatured Hb.
The aforementioned gel filtration chromatography was carried out on a 1.6 X 60-cm Sephacryl S-100 High Performance FPLC column (Amersham Bioscience) using PBS (pH 7.4) as eluting agent. The eluted Hb was dialyzed against 10 mM bis-Tris acetate, pH 6.5, prior to passage down a Q Sepharose Fast Flow column (Amersham Bioscience). The purified Hb was eluted by 10 mM bis-Tris acetate (pH6.5) and its concentration was determined by absorbance at 540 nm. Lower pH (pH 6.5) and ionic strength were employed in these studies, since these solution conditions are known to compensate for the loss of excluded volume effects that normally drive protein-protein interactions in the concentrated Hb environment of the intact erythrocyte.
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Determination of 2,3-bisphosphoglycerate concentration.
The concentration of 2,3-BPG on our Hb preparations was determined using a commercial kit (Roche Applied Science) with several modifications to improve the sensitivity of the determination. The sample was mixed with 0.5 volumes of 6 M HClO 4 (instead of admixing 5 volumes of 0.6 M HClO 4 ), and the spectrophotometric procedure was carried out by addition of 1000 µl of neutralized sample and 400 µl of 0.5 M triethanolamine buffer, instead of 100 µl of neutralized sample and 2 ml of 0.1 M triethanolamine buffer, as described in the manufacturer's instructions. With these modifications, the sensitivity and linearity of the determination was lowered to 10 µM.
Measurement of deoxyHb binding to cdb3 by analysis of O 2 dissociation curves.
Hb and cdb3 or its mutants were dialyzed against 10 mM bis-Tris acetate buffer, pH 6. Purified wild-type cdb3 (residues 1-379) or one of its mutants was immobilized onto Affi-Gel 15 beads (Bio-Rad) according to a previous protocol. 28 Briefly, 100 µl of packed beads were reacted with 4 nmol cdb3 or one of its mutants in a total volume of 2 ml. After mixing gently overnight at 4°C, unreacted Affi-Gel sites were blocked by incubating for 1 h in 1 M ethanolamine, pH 8.0. The resulting beads were washed with cold ddH 2 O and equilibrated in 10 mM bis-Tris acetate buffer, pH 6.5. The amount of cdb3 bound to the beads was determined by hydrolyzing the immobilized cdb3 in 1 N NaOH at 110°C for 2 h and measuring the protein concentration according to a Micro BCA Protein assay (Pierce Biotech) using bovine serum albumin as a standard and ethanolamine-derivatized gel as a control.
Derivatized beads were incubated for 1 h at room temperature under a stream of argon with Hb isolated as described above except 2,3-BPG was not removed. The incubated beads were washed 2x in 10 mM bis-Tris acetate buffer containing 35% PEG 1500 (pre-deoxygenated) to remove unbound Hb, and bound Hb was removed by stripping with 100 mM trisodium phosphate containing 500 mM NaCl (pH 7.4). The Hb eluted was quantified by determining its absorbance at 540 nm. The molar ratio of Hb bound to cdb3 was calculated as the ratio of bound Hb tetramers (MW: 66,000) to cdb3 monomers, using the MW of a wild type cdb3 monomer as 42,535, the MW of del (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) 
Results

Evaluation of the deoxyHb binding site on erythrocyte membrane band 3
Because band 3 binds preferentially, if not exclusively, to deoxyHb, the affinity of Hb for Although published results 14, 15, 28 suggest that the membrane binding site of deoxyHb resides at the N-terminus of band 3, the specific residues involved in the band 3 interaction were never established. To identify these residues, wild-type cdb3 (residues1-379), the exposed region at the C-terminus of band 3 (residues 872-911), and kidney cdb3 (residues 66-379) were compared for their abilities to shift the Hb-O 2 dissociation curve. As shown in Fig. 2 , wild-type cdb3 displaces the curve significantly to the right, shifting the apparent P 50 (oxygen partial pressure at which hemoglobin saturation is 50%) from 12 to 30 mm Hg, as expected. 15 In contrast, kidney cdb3, which lacks the first 65 amino acids of wild-type cdb3, has no effect on Hb-O 2 affinity. Furthermore, the C-terminus of band 3, whose sequence (902DEYDE906) is homologous to tandem sequences at the extreme N-terminus of band 3 (6DDYED10 and 19EEYED23), does not perturb O 2 dissociation. Taken together, these results suggest that the deoxyHb binding site on band 3 resides within the polypeptide's first 65 residues.
To more precisely define the amino acids involved in deoxyHb binding, various deletion mutants of cdb3 were expressed and examined. As shown in Fig. 3 D→N) and examined the impact of these mutations on Hb-O 2 affinity. As anticipated, substitution of the four acidic amino acids yielded a mutant protein (19QQYQN23) with significantly reduced affinity for deoxyHb (P 50~1 8mm Hg). Additional substitution of tyrosine 21 with alanine (19QQAQN23) yielded a second mutant with even less affinity for Hb (P 50~1 5mm Hg) (Fig. 4) . Because all mutations involving residues 12-23 either eliminated or significantly decreased cdb3-deoxyHb affinity, we conclude that the major site of deoxyHb binding to band 3 resides within this sequence.
Evaluation of mutations in sequences flanking residues 12-23 on Hb binding
Directly adjacent to residues 12-23 of band 3 lies a homologous sequence (1-MEELQDDYEDM-11) that we hypothesized might also contain a binding site for deoxyHb.
To test this hypothesis, we constructed a cdb3 mutant that lacked residues 1-11 and examined its effect on the Hb-O 2 dissociation curve. As shown in Fig. 5 , deletion of residues 1-11 [del(1-11)] not only failed to reduce deoxyHb binding affinity, but surprisingly shifted the Hb-O 2 dissociation curve further to the right (P 50~7 2mm Hg) than wild type cdb3 (P 50~3 0mm Hg). Therefore, despite the high homology to residues 12-23, the presence of residues 1-11 not only fails to enhance, but rather inhibits cdb3 interactions with deoxyHb.
To further establish the inhibitory nature of the NH 2 -terminal 11 residues on deoxyHb affinity, we mutated the central residues in this sequence to closely related counterparts (6DDYED10 → 6NNYQN10) and examined the resulting effect on Hb-O 2 dissociation.
Consistent with the previous data, these mutations also yielded a protein with exaggerated affinity for deoxyHb (P 50~7 4mm Hg) (Fig. 5) . In fact, the mutated cdb3 forced ~40% of Hb to remain deoxygenated at O 2 pressures normally found in the lungs (i.e.100 mm Hg, where Hb is usually 98% oxygenated). Furthermore, a cdb3 construct containing thioredoxin fused to the NH 2 -terminus of cdb3 [thioredoxin-(1-55)], which had been previously shown to sterically prevent proteins from interacting with residues 1-11, 21 also exhibited a much higher affinity for deoxyHb (P 50~8 0mm Hg) than wild type cdb3 (P 50~3 0mm Hg) (Fig. 5) .
together, we conclude residues 1-11 act to suppress cdb3 affinity for deoxyHb and that mutations within this sequence shift the Hb-O 2 dissociation curve to higher O 2 pressures.
We next explored the influence of residues downstream from the deoxyHb binding site on the Hb-O 2 binding equilibrium. As seen in Fig. 5 , deletion of residues 29-52 yielded a cdb3 mutant with the highest Hb-O 2 equilibrium shift yet measured (P 50~1 74mm Hg). Thus, in the presence of del(29-52) cdb3, oxygen saturation was not even approached at the maximum O 2 pressure achievable in the HEMOX analyzer (i.e., 200 mmHg). Therefore, we conclude that sequences on both sides of the deoxyHb binding site on band 3 (i.e. residues 12-23) act to suppress, rather than enhance Hb-band 3 affinity.
Direct measurement of deoxyHb binding to band 3
To verify that the observed shifts in the Hb-O 2 saturation curve accurately reflect differences in cdb3 affinity for deoxyHb, we measured deoxyHb binding to cdb3 directly using cdb3 immobilized on Affi-gel beads, as described in the Methods. Further, in order to simulate conditions that might exist inside the red cell, 2,3-BPG was not removed from the Hb preparation prior to band 3 binding analysis, yielding a Hb sample with a 2,3-BPG to Hb ratio of 0.82:1; i.e. a value within the reported physiological range 29 . As seen in Fig. 6 , the cdb3 construct found to exert virtually no effect on for deoxyHb is a consequence of adjacent sequences that both contribute to and inhibit the association.
Homology Analysis
Although O 2 regulation of red cell properties has not been extensively studied in other The question therefore arises whether the deoxyHb binding sequence on human band 3 might be conserved in these other species. Although amino acid insertions and deletions frequently occur near the NH 2 -termini of all band 3 homologs, a region of high homology can nevertheless be identified in mammalian and avian sequences, 35 but not in the sequences of fish (rainbow trout and zebrafish) band 3 homologs (Fig. 7) . Perhaps consistent with these observations, O 2 regulation of ion transport in mammalian and avian species exhibits an O 2 concentration dependence that follows the O 2 dissociation curve of Hb. 4, 13, 30 In contrast, the O 2 dependence of KCl cotransport in fish displays a P 50 value well below the P 50 of fish Hb for O 2 .
33,34
These results suggest that a mechanistically distinct pathway for O 2 regulation of ion transport may exist in fish red cells.
Discussion
We have provided evidence that 1) deoxyHb associates with band 3 at residues 12-23, Given the strong impact of band 3 on Hb-O 2 affinity, the question naturally arises whether band 3 might also participate in regulation of O 2 delivery. Unfortunately, two possible
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Because an average red cell contains ~270,000,000 copies of Hb (tetramer) and 1,200,000 copies of band 3, 36 less than 0.5% of the cell's Hb will ever have the opportunity to associate with band 3. Therefore, the impact of band 3 on global Hb-O 2 affinity must be negligible.
In contrast, Hb is also believed to catalyze the synthesis and release of nitric oxide (NO), [37] [38] [39] a second messenger that enhances blood flow by promoting vascular dilation. Importantly, NO production is thought to be controlled by the oxygenation state of Hb. [37] [38] [39] Because NO is rapidly inactivated upon its release, only NO that is produced at the membrane surface will likely escape the red cell and be available to modify vascular function. Therefore, the population of Hb proximal to band 3 may contribute most to NO-mediated regulation of the vasculature. [40] [41] [42] In this scenario, the impact of band 3 on NO delivery could be substantial.
As previously reported, 21 residues 1-23 of band 3 contain binding sites for glycolytic enzymes such as aldolase, GAPDH and PFK. When these enzymes are bound to band 3, they are partially inhibited, but when they are free, they are fully active. [21] [22] [23] Because there are ~500,000 copies of GAPDH, ~20 000 copies of aldolase, and ~ 6000 copies of PFK per red cell, 43, 44 sufficient numbers of band 3 exist to bind all of the above enzymes. However, since these glycolytic enzymes compete directly with deoxyHb for the NH 2 -terminus of band 3, the enzymes are displaced during erythrocyte deoxygenation. 16 This O 2 -dependent competition between glycolytic enzymes and deoxyHb for enzyme inhibitory sites on band 3
would be expected to lead to O 2 -dependent modulation of glucose metabolism. Indeed, glucose flux through glycolysis has been observed to increase, while flux through the pentose phosphate pathway has been seen to decrease during red cell deoxygenation. 45 This response is believed to be adaptive, since it allows for elevated NADPH production during periods of prolonged O 2 stress and enhanced ATP production during times of extended deoxygenation. Importantly, a recent comparison of glucose metabolism in wild type and band 3 knockout erythrocytes demonstrates that band 3 is essential for the O 2 -dependent switch from the pentose phosphate pathway to glycolysis. 45 Therefore, these studies collectively suggest that RBC oxygenation can regulate metabolism through a reversible association of deoxyHb with band 3.
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As noted in the Introduction, there is also evidence that O 2 can modulate erythrocyte membrane mechanical properties. The major linkage between the erythrocyte membrane bilayer and spectrin-based skeleton is provided by the ankyrin-band 3 bridge. 46 Although residues 175-185 constitute the major ankyrin-binding site on cdb3, other studies also indicate that the NH 2 -terminus of cdb3 lies proximal to a secondary cdb3-ankyrin binding site. 19 Thus, a monoclonal antibody to residues 1-10 of cdb3 can block ankyrin binding to band 3, and ankyrin association with cdb3 prevents p72 syk phosphorylation of cdb3 on Tyr 8 and Tyr
21
. 19 The observations that ankyrin association with KI-IOVs is prevented by deoxyHb, but not oxyHb (Stefanovic M and Low PS, unpublished data) and that deoxyHb binds to residues 12-23 of cdb3 provide a possible mechanism whereby red cell oxygenation state can alter membrane mechanical properties.
There is also reason to conjecture that the band 3-deoxyHb interaction can regulate ion transport in erythrocytes. Thus, the anion transport inhibitor, DIDS, is known to react almost exclusively with band 3 on (lysine 539 or lysine 542) near the outer surface of the erythrocyte membrane. 47, 48 Importantly, DIDS binding to this external site significantly alters Hb binding to the NH 2 -terminus of cdb3, 18 and deoxygenated cells 9 , has been shown to be inhibited in DIDS-labeled cells. 49, 50 Because there is no evidence that DIDS reacts with the KCl cotransporter, one possible explanation is that DIDS inhibition is mediated through an intimate association of the KCl transporter with band 3. Along similar lines, Fossel et al. 25 ,51 have presented evidence for structural communication between band 3 and the Na/K-ATPase, where Na + binding to the ATPase alters glyceraldehyde-3-phosphate dehydrogenase on cdb3. Since this conformational communication is also abrogated by band 3 labeling with DIDS, a related signal transduction pathway can be envisioned to account for oxygenation effects on Na + /K + transport 4, 8, 10 Because much remains to be learned about mechanisms of communication between band 3 and associated proteins, it will be important to test the above hypotheses in Finally, as noted above, previous studies have shown that a peptide comprising residues 1-11 of band 3 binds within the 2,3-BPG binding cleft of deoxyHb and shifts the O 2 dissociation curve to higher pressures. 15 Although no comparison of this NH 2 -terminal peptide with other band 3 peptides was ever pursued, these previous data nevertheless suggest that the isolated NH 2 -terminal 11 amino acids of band 3 exhibit affinity for deoxyHb.
The data reported here, however, demonstrate that either 1) removal or 2) mutagenesis of this peptide enhances rather than reduces band 3-deoxyHb affinity. Although an unequivocal explanation of this apparent discrepency cannot be offered, we hypothesize that residues 1-11 somehow inhibit access of deoxyHb to its higher affinity site on residues 12-23 of cdb3, thereby reducing the net affinity of the interaction. While other explanations are also possible, the total mutagenesis data nevertheless demonstrate that nature could have evolved either a much higher or lower affinity band 3-deoxyHb interaction had it been pre-dialyzed Hb was added prior to incubation for 1 h at room temperature with gentle agitation under argon. Beads were washed 2x with deoxygenated 35% PEG 1500 in 10 mM bis-tris acetate buffer ( pH6.5) to remove unbound Hb. Bound Hb was then determined by stripping the beads with 100 mM trisodium phosphate, 500 mM NaCl, pH 7.4 and measuring the absorbance of the eluate at 540 nm. The molar ratio of bound Hb to cdb3 was calculated as the ratio of bound Hb tetramers to cdb3 monomers. 
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For personal use only. on October 28, 2017. by guest www.bloodjournal.org From
Figure 5
Figure 6
